ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

ClinicalTrials.gov ID: NCT05037123

Public ClinicalTrials.gov record NCT05037123. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 3:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05037123
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
NYU Langone Health
Other
Enrollment
765 participants

Conditions and interventions

Interventions

  • Continuous ketamine infusion Drug
  • Ketamine + Saline Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 3, 2022
Primary completion
May 27, 2025
Completion
Aug 30, 2026
Last update posted
May 5, 2026

2022 – 2026

United States locations

U.S. sites
14
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
University of Arkansas Little Rock Arkansas 72205
Rush University Medical Center Chicago Illinois 60612
Brigham and Women's Hospital - Harvard University Chestnut Hill Massachusetts 02467
Mayo Clinic Rochester Minnesota 55905
Washington University at St. Louis Medical Center St Louis Missouri 63110
NYU Langone Health (Tisch Hospital, Kimmel Pavilion) New York New York 10016
New York Presbyterian Columbia University Irving Medical Center New York New York 10032
Memorial Sloan Kettering Cancer Center New York New York 10065
Montefiore Medical Center - Albert Einstein College of Medicine The Bronx New York 10467
University of Pittsburgh - Magee Women's Hospital Pittsburgh Pennsylvania 15213
University of Texas - Southwestern Medical Center Dallas Texas 75390
University of Texas - MD Anderson Cancer Center Houston Texas 77030
University of Washington Medical Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05037123, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05037123 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →